According to our study, 28% of MS patients (13/46) presented intrathecal IgM synthesis, as shown by an IgM index of ≥0.10 (13/13) or by the presence of IgM OCBs (4/13). This evidence concerns the gene CD40LG and myeloid sarcoma.